Molecular Assessment for Gastro-Esophageal Cancer
Conditions: Esophageal Cancer; Gastric Cancer; Barrett Esophagus Interventions: Diagnostic Test: Breath analysis; Diagnostic Test: Blood analysis Sponsors: KU Leuven Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Concurrent Programmed Cell Death Protein 1 Inhibitor and Radiotherapy With Immunonutrition Support for in Unresectable Esophageal Squamous Cell Carcinoma Patients
Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma; Sintilimab; Radiotherapy; Concurrent Chemoradiotherapy; Immunonutrition Interventions: Combination Product: Sintilimab + radiotherapy + enteral nutritional emulsion (TPF-T) Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Volume Outcome Relationships and Effects
Conditions: Esophageal Cancer Sponsors: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma; Sintilimab; Radiotherapy; Concurrent Chemoradiotherapy; Immunonutrition Interventions: Radiation: Radiotherapy; Drug: Programmed Cell Death Protein 1 Inhibitor; Dietary Supplement: Immunonutrition support Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
Conditions: Esophageal Cancer Interventions: Combination Product: Experimental: Arm 1 Organ preservation; Combination Product: Active Comparator: Arm 2 Surgery Sponsors: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
Conditions: Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Interventions: Drug: Adebrelimab; Drug: Apatinib; Drug: Tegafur Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Conditions: Esophageal Adenocarcinoma; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: OBP-301; Drug: Pembrolizumab Sponsors: Weill Medical College of Cornell University; Merck Sharp& Dohme LLC; Oncolys BioPharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy
Conditions: Esophageal Cancer Interventions: Device: Screening with swallowable esophageal cell-collection devices (SECD) Sponsors: OHSU Knight Cancer Institute; Kuni Foundation; Oregon Health and Science University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy
Conditions: Esophageal Squamous Cell Carcinoma; Surgery Interventions: Other: Whether there is type 2 diabetes mellitus before surgery Sponsors: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Sacituzumab govitecan Sponsors: National Taiwan University Hospital; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma
Conditions: Dysphagia Interventions: Device: Intermittent Oral-esophageal Tube Feeding; Device: Nasogastric Tube Feeding; Behavioral: comprehensive rehabilitation therapy Sponsors: Copka Sonpashan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Conditions: Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma Interventions: Drug: Zongertinib; Drug: Trastuzumab deruxtecan; Drug: Trastuzumab emtansine Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma
Conditions: Esophageal Cancer Interventions: Other: DIBH using ABC technique; Other: DIBH using VC technique Sponsors: University Medical Center Groningen Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes
Conditions: Esophageal Cancer; Sarcopenia Sponsors: Benaroya Research Institute; Imperial College London Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning
Conditions: Esophageal Cancer Interventions: Other: Collecting data from the medical record Sponsors: Centre Hospitalier Universitaire de Saint Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
